Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Thibaut du Fayet
CEO | Chief Executive Officer | 56 | 23.06.23 |
Eric Soyer
DFI | Director of Finance/CFO | 57 | 23.06.23 |
Pascal Birman
CTO | Chief Tech/Sci/R&D Officer | - | 23.06.23 |
Cindy Fevre
CTO | Chief Tech/Sci/R&D Officer | - | 23.06.23 |
Céline Breda
CTO | Chief Tech/Sci/R&D Officer | 54 | 23.06.23 |
Karine Charton
PRN | Corporate Officer/Principal | - | 23.06.23 |
General Counsel | - | 23.06.23 | |
Human Resources Officer | - | 23.06.23 | |
Jérôme Bailly
PRN | Corporate Officer/Principal | 45 | 23.06.23 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 63 | 23.06.23 | |
Hilde Windels
BRD | Director/Board Member | 59 | 23.06.23 |
Gil Beyen
BRD | Director/Board Member | 62 | 23.06.23 |
Martine George
BRD | Director/Board Member | 76 | 23.06.23 |
Director/Board Member | 66 | 23.06.23 | |
Didier Hoch
CHM | Chairman | 68 | 23.06.23 |
Leila Nicolas
BRD | Director/Board Member | - | 23.06.23 |
Robert Sebbag
BRD | Director/Board Member | 73 | 23.06.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 11 137 712 | 10 660 161 ( 95,71 %) | 270 ( 0,002429 %) | 95,71 % |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
250 | 0,00% | 813 $ |
Unternehmenskontakt
![Straße ERYTECH Pharma](https://cdn.zonebourse.com/static/address/35055710.png)
Sektor
Umsatz je Region
% 1. Jan. | Kap. | |
---|---|---|
+16,61 % | 122 Mrd. | |
+17,75 % | 112 Mrd. | |
+17,23 % | 25,91 Mrd. | |
-24,11 % | 19,33 Mrd. | |
-18,56 % | 16,17 Mrd. | |
-18,47 % | 15,56 Mrd. | |
-47,75 % | 14,65 Mrd. | |
+57,35 % | 14,34 Mrd. | |
+5,62 % | 14 Mrd. |